U.S. Markets close in 5 hrs 48 mins

See what the IHS Markit Score report has to say about Seattle Genetics Inc.

IHS Markit

Seattle Genetics Inc

NASDAQ/NGS:SGEN

Score: Positive (81)

1 day at current score.

Upgraded from Neutral on September 14th 2017

View full report here!

Summary


  • This company ranked positively in all 3 IHS Markit categories and the Healthcare sector
  • ETFs holding this stock are seeing positive inflows
  • Bearish sentiment is low
  • Economic output in this company's sector is expanding


Bearish sentiment

Short interest | Positive

Short interest is low for SGEN with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.

Money flow

ETF/Index ownership | Positive

ETF activity is positive. Over the last month, ETFs holding SGEN are favorable, with net inflows of $4.20 billion. Additionally, the rate of inflows is increasing.

Economic sentiment

PMI by IHS Markit | Positive

According to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is strong relative to the trend shown over the past year.

Credit worthiness

Credit default swap

CDS data is not available for this security.

Please send all inquiries related to the report to score@ihsmarkit.com.

Charts and report PDFs will only be available for 30 days after publishing.

This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.